Clinical value of ribs removal for treating middle-late stage primary liver cancer using HIFU plus TACE / 重庆医科大学学报
Journal of Chongqing Medical University
;
(12)1986.
Artículo
en Chino
| WPRIM
| ID: wpr-579501
ABSTRACT
0.05,Chi-square test).Conclusion:
Ribs removal can not improve the effects of HIFU plus TACE in the treatment of middle-late stage primary liver cancer significantly.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Idioma:
Chino
Revista:
Journal of Chongqing Medical University
Año:
1986
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS